<SEC-DOCUMENT>0001213900-18-007235-index.html : 20180605
<SEC-HEADER>0001213900-18-007235.hdr.sgml : 20180605
<ACCEPTANCE-DATETIME>20180605115015
ACCESSION NUMBER:		0001213900-18-007235
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180531
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180605
DATE AS OF CHANGE:		20180605

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Wize Pharma, Inc.
		CENTRAL INDEX KEY:			0001218683
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				880445167
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-52545
		FILM NUMBER:		18880433

	BUSINESS ADDRESS:	
		STREET 1:		5B HANAGAR STREET
		CITY:			HOD HASHARON
		STATE:			L3
		ZIP:			4527708
		BUSINESS PHONE:		972 472 260 0536

	MAIL ADDRESS:	
		STREET 1:		5B HANAGAR STREET
		CITY:			HOD HASHARON
		STATE:			L3
		ZIP:			4527708

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OphthaliX, Inc.
		DATE OF NAME CHANGE:	20120207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DENALI CONCRETE MANAGEMENT INC
		DATE OF NAME CHANGE:	20030213
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k053118_wizepharma.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: f8k053118_wizepharma.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>f8k053118ex10-1_wizepharma.htm
<DESCRIPTION>EXCLUSIVE DISTRIBUTION AGREEMENT DATED MAY 31, 2018
<TEXT>
Document 2 - file: f8k053118ex10-1_wizepharma.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>f8k053118ex99-1_wizepharma.htm
<DESCRIPTION>PRESS RELEASE DATED JUNE 5, 2018
<TEXT>
Document 3 - file: f8k053118ex99-1_wizepharma.htm

</DOCUMENT>
</SEC-DOCUMENT>